BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1790424)

  • 1. Supernatant cell counts from long-term bone marrow culture correlate with the speed of engraftment following autologous bone marrow transplantation.
    Jackson GH; Clarke AJ; Taylor P; Dickinson AM; Proctor SJ; Cattan AR
    Bone Marrow Transplant; 1991 Dec; 8(6):439-44. PubMed ID: 1790424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.
    Straetmans N; Ma DD; Herman P; Zenebergh A; Chang A; Deneys V; De Bruyère M; Ferrant A
    Bone Marrow Transplant; 1995 Mar; 15(3):421-8. PubMed ID: 7599567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
    Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
    Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
    Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose.
    Keever-Taylor CA; Klein JP; Eastwood D; Bredeson C; Margolis DA; Burns WH; Vesole DH
    Bone Marrow Transplant; 2001 Apr; 27(8):791-800. PubMed ID: 11477435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of engraftment after repeated autologous bone marrow transplantation.
    van Besien K; Nichols CR; Tricot G; Langefeld C; Miller ME; Akard L; English DK; Graves VL; Cheerva A; McCarthy LJ
    Exp Hematol; 1990 Aug; 18(7):785-8. PubMed ID: 2165911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency and proliferative potential of megakaryocytic colony-forming cells (Meg-CFC) in cord blood, cytokine-mobilized peripheral blood and bone marrow, and their correlation with total CFC numbers: implications for the quantitation of Meg-CFC to predict platelet engraftment following cord blood transplantation.
    Drygalski A; Xu G; Constantinescu D; Kashiwakura I; Farley T; Dobrila L; Rubinstein P; Adamson JW
    Bone Marrow Transplant; 2000 May; 25(10):1029-34. PubMed ID: 10828861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cryopreservation of bone marrow for autologous transplantation.
    Attarian H; Feng Z; Buckner CD; MacLeod B; Rowley SD
    Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation.
    Bacigalupo A; Piaggio G; Podesta M; Figari O; Benvenuto F; Sogno G; Tedone E; Raffo MR; Grassia L; Ferrero R
    Bone Marrow Transplant; 1995 Feb; 15(2):221-6. PubMed ID: 7773210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery.
    Faulkner LB; Lindsley KL; Kher U; Heller G; Black P; Finlay JL
    Bone Marrow Transplant; 1996 Mar; 17(3):389-94. PubMed ID: 8704692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
    Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.
    Drayer AL; Smit Sibinga CT; Esselink MT; de Wolf JT; Vellenga E
    Ann Hematol; 2002 Apr; 81(4):192-7. PubMed ID: 11976820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system.
    Hirao A; Kawano Y; Takaue Y; Suzue T; Abe T; Sato J; Saito S; Okamoto Y; Makimoto A; Kawahito M
    Exp Hematol; 1994 Jun; 22(6):521-6. PubMed ID: 8187849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.